Avidity Partners Management LP lessened its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 18.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 615,000 shares of the biotechnology company’s stock after selling 136,600 shares during the quarter. Blueprint Medicines accounts for approximately 2.1% of Avidity […]
Stephens assumed coverage on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a report published on Tuesday, MarketBeat.com reports. The firm issued an overweight rating and a $140.00 price objective on the biotechnology company’s stock. Other equities analysts have also issued research reports about the company. SVB Leerink raised Blueprint Medicines from an underperform […]
Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 4,540,000 shares, a growth of 6.8% from the April 15th total of 4,250,000 shares. Based on an average daily volume of 830,500 shares, […]
Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) was the recipient of a significant growth in short interest in April. As of April 30th, there was short interest totalling 4,540,000 shares, a growth of 6.8% from the April 15th total of 4,250,000 shares. Based on an average trading volume of 830,500 shares, the days-to-cover ratio […]
The Goldman Sachs Group Increases Blueprint Medicines (NASDAQ:BPMC) Price Target to $168 00 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.